Table 1 Summary table of study population by infection status and sex.
Variable | Infected (n = 335, 50.15%) | Not infected (n = 333, 49.85%) | ||
|---|---|---|---|---|
Demographic parameters | ||||
Sex | Women (n = 192, 57.31%) | Men (n = 143, 42.69%) | Women (n = 184, 55.26%) | Men (n = 149, 44.74%) |
Age (mean ± SD) | 59.3 ± 10.7 | 62.7 ± 11.5 | 64.8 ± 10.7 | 65.8 ± 11.1 |
Underlying conditions | ||||
Type 2 diabetes mellitus (T2DM) | 13 (6.77%) | 13 (9.10%) | 19 (10.33%) | 14 (9.40%) |
Cancer SHIP-START-3 | 7 (3.65%) | 6 (4.20%) | 6 (3.26%) | 6 (4.03%) |
Cancer SHIP-START-4 | 18 (9.38%) | 20 (13.99%) | 20 (10.87%) | 16 (10.74%) |
Myocardial infarction | 0 (0.00%) | 6 (4.20%) | 3 (1.63) | 7 (4.70%) |
Stroke | 3 (1.56%) | 4 (2.80%) | 2 (1.10%) | 4 (2.68%) |
Behavioral parameter | ||||
Current smoker SHIP-START-3 | 37 (19.27%) | 13 (9.10%) | 35 (19.02%) | 29 (19.46%) |
Current smoker SHIP-START-4 | 33 (17.19%) | 8 (5.59%) | 27 (14.67%) | 25 (16.78%) |
Vaccination | ||||
0-vaccine | 27 (14.06%) | 29 (20.28%) | 8 (4.35%) | 11 (7.38%) |
1-vaccine | 4 (2.08%) | 2 (1.40%) | 2 (1.09%) | 4 (2.68%) |
2- vaccines | 21 (10.94%) | 12 (8.39%) | 11 (5.98%) | 11 (7.38%) |
3-vaccines | 133 (69.27%) | 86 (60.14%) | 124 (67.39%) | 88 (59.06%) |
4-vaccines | 7 (3.65%) | 14 (9.79%) | 39 (21.20%) | 35 (23.49%) |
Total | 192 | 143 | 184 | 149 |